19F magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement

Magnetic Resonance Imaging

Volumn 22, Issue 6, 2004, Pages 855-860

  Kimura, Atsuomi ^a   Narazaki, Michiko ^b   Kanazawa, Yoko ^b   Fujiwara, Hideaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

19F MRI; chemical shift selection; FAST spin echo; perfluorooctanoic acid

Indexed keywords

FLUORINE DERIVATIVE; LIPOSOME; PERFLUOROOCTANOIC ACID; PHOSPHATIDYLCHOLINE; SUCROSE; TRIFLUOROACETAMIDE DERIVATIVE; DIAGNOSTIC AGENT; FLUORINE; FLUOROCARBON; OCTANOIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; ENCAPSULATION; FEMALE; IMAGING SYSTEM; LIVER; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE DISTRIBUTION; ANIMAL; FEASIBILITY STUDY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; STOMACH;

ILEX COOKII;

ANIMALS; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUOROCARBONS; LIPOSOMES; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED ICR; OCTANOIC ACIDS; STOMACH; TISSUE DISTRIBUTION;

EID: 3242673607     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2004.01.060     Document Type: Article

References (23)

1. Guethner R.A., Vietor M.L. Surface active materials from perfluorocarboxylic and perfluorosulphonic acid. Ind Eng Chem Prod Rec Dev. 1:1962;165-169
2. Ubel F.A., Sorenson S.D., Roach D.E. Health status of plant workers exposed to fluorochemicals - a preliminary report. Am Ind Hyg Assoc J. 41:1980;584-589
3. Krafft M.P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Deliv Rev. 47:2001;209-228
4. Olson C.T., Andersen M.E. The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol Appl Pharmacol. 70:1983;362-372
5. Hanhijarvi H., Ophaug R.H., Singer L. The sex-related differences in perfluorooctanoate excretion in the rat. Proc Soc Exp Biol Med. 171:1982;50-55
6. Uy-Yu N., Kawashima Y., Kozuka H. Comparative studies on sex-related difference in biochemical responses to perfluorooctanoic acid between rats and mice. Biochem Pharmacol. 39:1990;1492-1495
7. Kawashima Y., Kobayashi H., Miura H., Kozuka H. Characterization of hepatic response of rat to administration of perfluorooctanoic acid and perfluorodecanoic acid at low levels. Toxicology. 99:1995;169-178
8. Van den Heuvel J.P., Kuslikis B.I., Van Rafelghem M.J., Peterson R.E. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol. 6:1991;83-92
9. Ylinen M., Auriola S. Tissue distribution and elimination of perfluorodecanoic acid in the rat after single intraperitoneal administration. Pharmacol Toxicol. 66:1990;45-48
10. 19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation. Magn Reson Med. 47:2002;82-89
11. 19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging. Magn Reson Med. 41:1999;80-86
12. Sotak C.H., Hees P.S., Huang H.N., Hung M.H., Krespan C.G., Raynolds S. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn Reson Med. 29:1993;188-195
13. 19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magn Reson Med. 42:1999;1039-1047
14. Sottani C., Minoia C. Quantitative determination of perfluorooctanoic acid ammonium salt in human serum by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 16:2002;650-654
15. Kudo N., Bandai N., Kawashima Y. Determination of perfluorocarboxylic acids by gas-liquid chromatography in rat tissues. Toxicol Lett. 99:1998;183-190
16. Han X., Snow T.A., Kemper R.A., Jepson G.W. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol. 16:2003;775-781
17. Reo N.V., Adinehzadeh M. NMR spectroscopic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis in rats exposed to peroxisome proliferators - a class of nongenotoxic hepatocarcinogens. Toxicol Appl Pharmacol. 164:2000;113-126
18. Goecke C.M., Jarnot B.M., Reo N.V. A comparative toxicological investigation of perfluorocarboxilic acids in rats by fluorine-19 NMR spectroscopy. Chem Res Toxicol. 5:1992;512-519
19. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging. NMR Biomed. 10:1997;35-41
20. Kanazawa Y., Momozono Y., Yamane H., Haradahira T., Maeda M., Kojima M. Metabolic pathway of 2-deoxy-2fluoro-D-glucose and 2-deoxy-2fluoro-D-mannose in mice. Chem Pharm Bull. 35:1987;895-898
21. 2 measurements using an OSIRIS-CPMG method - application to measurements of blood oxygenation and transverse relaxation free of diffusion effect. NMR Biomed. 7:1994;343-348
22. Luebker D.J., Hansen K.J., Bass N.M., Butenhoff J.L., Seacat A.M. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology. 176:2002;175-185
23. Kudo N., Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci. 28:2003;49-57